Cargando…
Androgen receptor in breast cancer and its clinical implication
Breast cancer is a heterogeneous group of diseases characterized by diverse subtypes. Currently, the classification of breast cancer is based on the status of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2). In addition to these receptors, the...
Autores principales: | Hackbart, Hannah, Cui, Xiaojiang, Lee, Jin Sun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632549/ https://www.ncbi.nlm.nih.gov/pubmed/37946721 http://dx.doi.org/10.21037/tbcr-23-44 |
Ejemplares similares
-
CDK4/6 Inhibitor Resistance in Hormone Receptor-Positive Metastatic Breast Cancer: Translational Research, Clinical Trials, and Future Directions
por: Lee, Jin Sun, et al.
Publicado: (2023) -
The role of the androgen receptor in ovarian cancer carcinogenesis and its clinical implications
por: Zhu, Haiyan, et al.
Publicado: (2016) -
The Androgen Receptor in Breast Cancer
por: Giovannelli, Pia, et al.
Publicado: (2018) -
Clinical Implications of Androgen-Positive Triple-Negative Breast Cancer
por: Brumec, Maša, et al.
Publicado: (2021) -
The effect of androgen receptor expression on clinical characterization of metastatic breast cancer
por: Kim, Ji-Yeon, et al.
Publicado: (2017)